{
  "disease_name": "Pyridoxine-dependent epilepsy",
  "orpha_code": "3006",
  "drugs": [
    {
      "name": "BUCCOLAM",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/325650?name=3006&mode=orpha&region=",
      "regulatory_id": "325650",
      "orpha_substance_code": "ORPHA:693802",
      "details": [
        "BUCCOLAM(Tradename                        - 05/09/2011)Disease(s) concernedORPHA:98259 Childhood-onset epilepsy syndromeORPHA:98260 Adolescent-onset epilepsy syndromeORPHA:693802 Neonatal-infantile onset epilepsy syndrome",
        "BUCCOLAM(Tradename                        - 05/09/2011)",
        "(Tradename                        - 05/09/2011)",
        "Disease(s) concernedORPHA:98259 Childhood-onset epilepsy syndromeORPHA:98260 Adolescent-onset epilepsy syndromeORPHA:693802 Neonatal-infantile onset epilepsy syndrome",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/325618?name=3006&mode=orpha&region=&status=all",
          "text": "BUCCOLAM",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/98259",
          "text": "ORPHA:98259 Childhood-onset epilepsy syndrome",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/98260",
          "text": "ORPHA:98260 Adolescent-onset epilepsy syndrome",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/693802",
          "text": "ORPHA:693802 Neonatal-infantile onset epilepsy syndrome",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/325650?name=3006&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": "ORPHA:98260 Adolescent-onset epilepsy syndrome\n                                \n\n\n\n\n                                    ORPHA:693802 Neonatal-infantile onset epilepsy syndrome\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "LIBERVANT",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/673903?name=3006&mode=orpha&region=",
      "regulatory_id": "673903",
      "orpha_substance_code": "ORPHA:166463",
      "details": [
        "LIBERVANT(Tradename                        - 26/04/2024)Disease(s) concernedORPHA:166463 Epilepsy syndrome",
        "LIBERVANT(Tradename                        - 26/04/2024)",
        "(Tradename                        - 26/04/2024)",
        "Disease(s) concernedORPHA:166463 Epilepsy syndrome",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/673890?name=3006&mode=orpha&region=&status=all",
          "text": "LIBERVANT",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/166463",
          "text": "ORPHA:166463 Epilepsy syndrome",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/673903?name=3006&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": "More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "SEZABY",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/635898?name=3006&mode=orpha&region=",
      "regulatory_id": "635898",
      "orpha_substance_code": "ORPHA:693802",
      "details": [
        "SEZABY(Tradename                        - 17/11/2022)Disease(s) concernedORPHA:693802 Neonatal-infantile onset epilepsy syndrome",
        "SEZABY(Tradename                        - 17/11/2022)",
        "(Tradename                        - 17/11/2022)",
        "Disease(s) concernedORPHA:693802 Neonatal-infantile onset epilepsy syndrome",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/635897?name=3006&mode=orpha&region=&status=all",
          "text": "SEZABY",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/693802",
          "text": "ORPHA:693802 Neonatal-infantile onset epilepsy syndrome",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/635898?name=3006&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": "More details on the regulatory status",
      "regions": [
        "US"
      ]
    }
  ],
  "processing_timestamp": "2025-07-07T06:03:41.158692",
  "run_number": 1,
  "total_drugs_found": 3,
  "search_url": "https://www.orpha.net/en/drug?diseaseName=Pyridoxine-dependent+epilepsy&orphaCode=3006&name=3006&region=&mode=orpha&status=all",
  "search_params": {
    "diseaseName": "Pyridoxine-dependent epilepsy",
    "orphaCode": "3006",
    "name": "3006",
    "region": "",
    "mode": "orpha",
    "status": "all"
  }
}